Clinical evaluation for connective tissue dysplasia should be routinely performed in CAH patients, especially those harboring a CYP21A2 deletion (Merke et al., 2013,) as CAH-X recently considered a subtype of CAH (Lao and Merke, 2021; Miller, 2021). Here, CYP21A2 is linked to congenital adrenal hyperplasia.